The global Inflammatory Bowel Disease Treatment Market is benefiting from rising disease prevalence, growing adoption of advanced biologics, expanding access to targeted therapies, increasing awa...
Posted by Mayur on September 08 2026 at 02:21 PM
public
The global bowel management systems market is witnessing steady development as healthcare providers increasingly adopt solutions designed to improve the management of fecal incontinence, bowel dy...
Posted by Surbhi on July 09 2026 at 06:02 PM
public
IL-23 inhibitors in IBD treatment — the selective biologics targeting the p19 subunit of interleukin-23 (risankizumab/Skyrizi, guselkumab/Tremfya, mirikizumab/Omvoh) demonstrating superior effica...
